This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Instytut Farmaceutyczny. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Wojciech Szczepek: Innovator in Pharmaceutical Chemistry
Introduction
Wojciech Szczepek is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for synthesizing important pharmaceutical compounds. With a total of 2 patents, his work has the potential to impact the treatment of various medical conditions.
Latest Patents
Wojciech Szczepek's latest patents include the invention of crystalline polymorphs of methanesulfonic acid addition salts of Imatinib. This invention focuses on the synthesis of crystalline α-form of Imatinib methanesulfonate, along with a novel acid addition salt of a specific compound with methanesulfonic acid. Additionally, he has developed an improved process for the preparation of imatinib base, which involves several steps that utilize simple starting materials while avoiding laborious isolation and purification of intermediates.
Career Highlights
Wojciech Szczepek is associated with the Instytut Farmaceutyczny, where he has been instrumental in advancing pharmaceutical research. His innovative approaches to drug synthesis have garnered attention in the scientific community, showcasing his expertise in the field.
Collaborations
He has collaborated with notable colleagues, including Lukasz Kaczmarek and Bogdan Zagrodzki, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.
Conclusion
Wojciech Szczepek's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in drug development and synthesis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile